Progressive vs. Non-progressive Water-based Aerobic Training on Type 2 Diabetes Control: a Randomized Clinical Trial
PAT-DM2
Effects of Progressive vs. Non-progressive Water-based Aerobic Training on Type 2 Diabetes Control: a Randomized Clinical Trial
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
This is a randomized clinical trial with the aim to evaluate the effects of two water-based aerobic training programs (walking or running in shallow pool) on type 2 diabetes control. The sample will be composed by 50 individuals with type 2 diabetes, of both sexes, aged between 40 and 70 years, who will be randomized into water-based progressive aerobic training (PAT, n=25) and water-based non-progressive aerobic training (NPAT, n=25). Both trainings will have 12 weeks of duration with 3 weekly sessions (of 50 minutes each). Biochemical, cardiorespiratory fitness, maximum strength, body composition and functional mobility variables, as also quality of life, sleep quality and depressive symptoms will be analyzed before and after the 12 weeks of training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus-type-2
Started Jun 2019
Shorter than P25 for not_applicable diabetes-mellitus-type-2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2019
CompletedFirst Posted
Study publicly available on registry
May 30, 2019
CompletedStudy Start
First participant enrolled
June 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2019
CompletedJune 4, 2019
June 1, 2019
5 months
May 27, 2019
June 2, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glycated Hemoglobin levels (HbA1c)
Blood samples will be used to analyze glycated hemoglobin levels (%)
Change from baseline levels of glycated hemoglobin to 12 weeks of intervention.
Secondary Outcomes (23)
Fasting plasma glucose
At baseline and after a 12-week period
Fasting insulin
At baseline and after a 12-week period
Insulin-resistance index (HOMA-IR)
At baseline and after a 12-week period
Total cholesterol
At baseline and after a 12-week period
High density lipoprotein
At baseline and after a 12-week period
- +18 more secondary outcomes
Study Arms (2)
Progressive aerobic training
EXPERIMENTALWater-based aerobic training performed with progression in the training variables. The intervention will be performed during 12 weeks, with 3 weekly sessions (of 50 minutes each), of walking/running in shallow pool.
Non-progressive aerobic training
EXPERIMENTALWater-based aerobic training performed without progression in the training variables. The intervention will be performed during 12 weeks, with 3 weekly sessions (of 50 minutes each), of walking/running in shallow pool.
Interventions
The intervention will comprise walking/running in shallow pool with progression in the training variables. The training will have 12 weeks of duration with 3 weekly sessions (of 50 minutes each).
The intervention will comprise walking/running in shallow pool without progression in the training variables. The training will have 12 weeks of duration with 3 weekly sessions (of 50 minutes each).
Eligibility Criteria
You may qualify if:
- Individuals with type 2 diabetes, of both sexes, aged between 40 and 70 years.
- Be under medical treatment with oral hypoglycemic agents and / or insulin;
- Not be engaged in regular exercise (regular exercise was defined as performing any type of physical training for at least 20 minutes three or more days a week).
You may not qualify if:
- Presence of:
- uncontrolled hypertension;
- autonomic neuropathy;
- severe peripheral neuropathy;
- proliferative diabetic retinopathy;
- severe non-proliferative diabetic retinopathy;
- uncompensated heart failure;
- peripheral amputations;
- chronic kidney failure;
- body mass index (BMI)\> 45.0 kg/m2;
- to have some muscle or joint impairment that prevents the performance of physical exercises safely.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luiz FM Kruel, phd
Federal University of Rio Grande do Sul
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
May 27, 2019
First Posted
May 30, 2019
Study Start
June 10, 2019
Primary Completion
October 30, 2019
Study Completion
November 15, 2019
Last Updated
June 4, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share